News

Filter

Current filters:

UK

176 to 185 of 96176 results

AbbVie links with Calico in up to $1.5 billion effort on drug discovery

AbbVie links with Calico in up to $1.5 billion effort on drug discovery

04-09-2014

US pharma company AbbVie has entered a novel R&D collaboration with recently-formed Calico, intended…

AbbVieBiotechnologycalicoNeurologicalOncologyResearch

Infinity and AbbVie collaborate on duvelisib in deal worth up to $805 million

Infinity and AbbVie collaborate on duvelisib in deal worth up to $805 million

03-09-2014

US drug discovery firm Infinity Pharmaceuticals has entered into a global collaboration with AbbVie to…

AbbVieduvelisibInfinity PharmaceuticalsIPI-145LicensingOncologyPharmaceutical

EU marketing authorization for ViiV Healthcare HIV drug Triumeq

EU marketing authorization for ViiV Healthcare HIV drug Triumeq

03-09-2014

The European Commission has granted marketing authorization for ViiV Healthcare’s Triumeq (dolutegravir…

Anti-viralsEuropeGlaxoSmithKlinePharmaceuticalRegulationTriumeqViiV Healthcare

US HHS contracts with Mapp Biopharmaceutical to develop Ebola drug

03-09-2014

The US Department of Health and Human Services has awarded a $25 million contract to Mapp Biopharmaceutical…

Anti-viralsBiotechnologyFinancialMapp BiopharmaceuticalResearchTropical diseasesUSAZMapp

Teva gets positive UK judgment in case against AstraZeneca

Teva gets positive UK judgment in case against AstraZeneca

03-09-2014

A positive judgment has been given by the UK High Court in support of Israeli generic drug giant Teva…

AstraZenecaDuoResp SpiromaxGenericsLegalPatentsRespiratory and PulmonarySymbicortTeva Pharmaceutical IndustriesUK

Richard Pasternak to replace Jean-Pierre Garnier as chairman of Cerenis

Richard Pasternak to replace Jean-Pierre Garnier as chairman of Cerenis

03-09-2014

French biotechnology company Cerenis has appointed Richard Pasternak as chairman of the board of directors.

Nabriva appoints Colin Broom as chief executive

Nabriva appoints Colin Broom as chief executive

03-09-2014

Austrian biotech company Nabriva Therapeutics has appointed Colin Broom as chief executive.

BoardroomNabriva Therapeutics

Luye Pharma to acquire majority stake in Beijing Jialin for $599 million

Luye Pharma to acquire majority stake in Beijing Jialin for $599 million

03-09-2014

Hong Kong-based Luye Pharma has entered into an agreement to purchase a 57.98% stake of Beijing Jialin…

Beijing Jialin PharmaceuticalCardio-vascularChinaLuye PharmaMergers & AcquisitionsPharmaceutical

Strong Ph IIb results with Dezima’s CETP inhibitor TA-8995 in dyslipidemia

Strong Ph IIb results with Dezima’s CETP inhibitor TA-8995 in dyslipidemia

03-09-2014

Privately-held Dutch biotech firm Dezima Pharma says it has received very positive results in its Phase…

BiotechnologyCardio-vascularDEZ-001Dezima PharmaMitsubishi TanabeResearchTA-8995

176 to 185 of 96176 results

Company Spotlight

ImmunoGen

ImmunoGen

Back to top